A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

Clinical trial NCT00284804 · COMPLETED

Trial details

NCT number: NCT00284804
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin's Disease

Start date: 2005-11-01
Primary completion: 2008-05-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.